Dose and effect of methyl-2-benzimidazolylcarbamate in the "mammalian spot test", an in vivo method for the detection of genetic alterations in somatic cells of mice.
In the spot test, mouse embryos which are heterozygous for four different recessive coat-colour genes are treated in utero by injection of a mutagen into the peritoneal cavity of the mother or by other appropriate routes of administration. If this treatment leads in a pigment precursor cell to an alteration of the wild type allele of one of the genes under study or to its loss, a colour spot in the adult coat may be seen. Peroral application of 100-300 mg methyl-2-benzimidazolylcarbamate (MBC)/kg to the mother during the tenth day postconception led to an increase in the frequency of colour spots in the coats of offspring. The data are consistent with the hypothesis that MBC is a point mutagen.
D000483:Alleles; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D002219:Carbamates / Q000494:pharmacology*; D003116:Color; D004622:Embryo, Mammalian / Q000187:drug effects; D005020:Ethyl Methanesulfonate / Q000494:pharmacology; D005260:Female; D005787:Gene Frequency; D005796:Genes; D006197:Hair; D006579:Heterozygote; D008722:Methods; D009153:Mutagens / Q000494:pharmacology*; D011247:Pregnancy; D051381:Rats
D001562:Benzimidazoles; D002219:Carbamates; D009153:Mutagens; D005020:Ethyl Methanesulfonate